Medial septum parvalbumin‐expressing inhibitory neurons are impaired in a mouse model of Dravet syndrome
Epilepsia · 2025
DOI: 10.1111/epi.18532 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2025. Verfasst von Limei Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA. Hauptthemen laut MEDLINE: Parvalbumins, Epilepsies, Myoclonic, Septal Nuclei, Neurons. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NINDS NIH HHS, Kenneth Eisenberg Taubman Emerging Scholar Award, National Institute of Neurological Disorders and Stroke.
Abstract (Originalsprache)
Objective
Dravet syndrome (DS) is a severe neurodevelopmental disorder caused by pathogenic variants in the SCN1A gene, which encodes the voltage‐gated sodium channel Na v 1.1 α subunit. Experiments in animal models of DS—including the haploinsufficient Scn1a +/− mouse—have identified impaired excitability of interneurons in the hippocampus and neocortex; this is thought to underlie the treatment‐resistant epilepsy that is a prominent feature of the DS phenotype. However, additional brain structures, such as the medial septum (MS), also express SCN1A. The MS is known to play an important role in cognitive function and thus may contribute to the intellectual impairment that also characterizes DS.
Methods
In this study, we employed whole cell patch clamp recordings in acute brain slices to characterize the electrophysiological properties of MS neurons in Scn1a +/− mice versus age‐matched wild‐type littermate controls.
Results
We found no discernible genotype‐related differences in MS cholinergic neurons, but significant dysfunction within MS parvalbumin‐expressing (PV) inhibitory neurons in Scn1a +/− mice. We further identified heterogeneity of firing patterns among MS PV neurons, and additional genotype differences in the proportion of subtype representation. Significance These results confirm that the MS is an additional locus of pathology in DS and may contribute to comorbidities such as cognitive impairment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
- Michigan Neuroscience Institute, University of Michigan, Ann Arbor, Michigan, USA.
ORCID-Profile: Joanna Mattis
Förderung
- NINDS NIH HHS
- Kenneth Eisenberg Taubman Emerging Scholar Award
- National Institute of Neurological Disorders and Stroke
Zitieren
APA
Zhu, L., Demetriou, Y., Barden, J., Disla, J., Zhao, M., & Mattis, J. (2025). Medial septum parvalbumin‐expressing inhibitory neurons are impaired in a mouse model of Dravet syndrome. Epilepsia. https://doi.org/10.1111/epi.18532
Vancouver
Zhu L, Demetriou Y, Barden J, Disla J, Zhao M, Mattis J. Medial septum parvalbumin‐expressing inhibitory neurons are impaired in a mouse model of Dravet syndrome. Epilepsia. 2025. doi:10.1111/epi.18532
BibTeX
@article{Zhu2025,
author = {Zhu, Limei and Demetriou, Yiannos and Barden, Joseph and Disla, Juan and Zhao, Meiling and Mattis, Joanna},
title = {Medial septum parvalbumin‐expressing inhibitory neurons are impaired in a mouse model of Dravet syndrome},
journal = {Epilepsia},
year = {2025},
doi = {10.1111/epi.18532}
}
EUVIMED